Clinical Trial Update: Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013) [Phase 3]

View source ↗

Summary

Phase 3 trial of ceftolozane/tazobactam plus metronidazole in Japanese adults with complicated intra-abdominal infection has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Intra-abdominal Infection

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)
• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Intra-abdominal Infection, Complicated Intra-abdominal Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-07-12